Literature DB >> 20544265

Increased serum levels of epidermal growth factor in children with autism.

Elvan Işeri1, Esra Güney, Mehmet F Ceylan, Ayşegül Yücel, Arzu Aral, Sahin Bodur, Sahnur Sener.   

Abstract

The etiology of autism is unclear, however autism is considered as a multifactorial disorder that is influenced by neurological, environmental, immunological and genetic factors. Growth factors, including epidermal growth factor (EGF), play an important role in the cellular proliferation and the differentiation of the central and peripheral nervous system. In this study we hypothesized that EGF may play a role in the pathophysiology of autism and examined serum EGF levels in children with autism. We measured serum levels of EGF in the 27 autistic children and 28 age- matched normal controls. The serum levels of EGF in the subjects with autism were significantly higher than those of normal control subjects. However, there were no correlations between serum EGF levels and clinical variables in the subjects with autism. This is the first report demonstrating the increased serum levels of EGF in children with autism. This study suggests that increased levels of EGF might have an importance in the pathophysiology of autism.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20544265     DOI: 10.1007/s10803-010-1046-3

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN: 0162-3257


  28 in total

1.  Characterization of human epidermal growth factor in human serum and urine under native conditions.

Authors:  Cemalettin Aybay; Resul Karakus; Aysegul Yucel
Journal:  Cytokine       Date:  2006-09-05       Impact factor: 3.861

2.  Epidemiology of autistic disorder and other pervasive developmental disorders.

Authors:  Eric Fombonne
Journal:  J Clin Psychiatry       Date:  2005       Impact factor: 4.384

3.  Urinary epidermal and insulin-like growth factor excretion in autistic children.

Authors:  B Anlar; F Oktem; B Bakkaloglu; M Haliloglu; H Oguz; F Unal; B Pehlivanturk; B Gokler; C Ozbesler; N Yordam
Journal:  Neuropediatrics       Date:  2007-06       Impact factor: 1.947

4.  Epidermal growth factor and basic fibroblast growth factor protect dopaminergic neurons from glutamate toxicity in culture.

Authors:  D Casper; M Blum
Journal:  J Neurochem       Date:  1995-09       Impact factor: 5.372

Review 5.  The role of epidermal growth factor and its receptors in mammalian CNS.

Authors:  Richard Wing Chuen Wong; Laurent Guillaud
Journal:  Cytokine Growth Factor Rev       Date:  2004 Apr-Jun       Impact factor: 7.638

6.  Increased levels of serum basic fibroblast growth factor in schizophrenia.

Authors:  Kenji Hashimoto; Eiji Shimizu; Naoya Komatsu; Michiko Nakazato; Naoe Okamura; Hiroyuki Watanabe; Chikara Kumakiri; Naoyuki Shinoda; Shin-ichi Okada; Nori Takei; Masaomi Iyo
Journal:  Psychiatry Res       Date:  2003-10-15       Impact factor: 3.222

7.  Toward objective classification of childhood autism: Childhood Autism Rating Scale (CARS).

Authors:  E Schopler; R J Reichler; R F DeVellis; K Daly
Journal:  J Autism Dev Disord       Date:  1980-03

8.  Trophic actions of transforming growth factor alpha on mesencephalic dopaminergic neurons developing in culture.

Authors:  T Alexi; F Hefti
Journal:  Neuroscience       Date:  1993-08       Impact factor: 3.590

9.  Abnormal expression of epidermal growth factor and its receptor in the forebrain and serum of schizophrenic patients.

Authors:  T Futamura; K Toyooka; S Iritani; K Niizato; R Nakamura; K Tsuchiya; T Someya; A Kakita; H Takahashi; H Nawa
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

10.  EGF enhances the survival of dopamine neurons in rat embryonic mesencephalon primary cell culture.

Authors:  D Casper; C Mytilineou; M Blum
Journal:  J Neurosci Res       Date:  1991-10       Impact factor: 4.164

View more
  11 in total

1.  Risperidone-related improvement of irritability in children with autism is not associated with changes in serum of epidermal growth factor and interleukin-13.

Authors:  Zuzana Tobiasova; Klaas H B van der Lingen; Lawrence Scahill; James F Leckman; Yan Zhang; Wookjin Chae; James T McCracken; Christopher J McDougle; Benedetto Vitiello; Elaine Tierney; Michael G Aman; L Eugene Arnold; Liliya Katsovich; Pieter J Hoekstra; Fred Volkmar; Alfred L M Bothwell; Ivana Kawikova
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-11-09       Impact factor: 2.576

2.  Rescue of social behavior impairment by clozapine and alterations in the expression of neuronal receptors in a rat model of neurodevelopmental impairment induced by GRPR blockade.

Authors:  Juliana Presti-Torres; Vanessa Athaíde Garcia; Arethuza Dornelles; Luís Henrique Halmenschlager; Luisa Azambuja Alcalde; Gustavo Vedana; Eduardo Pacheco Rico; Maurício Reis Bogo; Gilberto Schwartsmann; Rafael Roesler; Nadja Schröder
Journal:  J Neural Transm (Vienna)       Date:  2011-08-17       Impact factor: 3.575

3.  Impaired carbohydrate digestion and transport and mucosal dysbiosis in the intestines of children with autism and gastrointestinal disturbances.

Authors:  Brent L Williams; Mady Hornig; Timothy Buie; Margaret L Bauman; Myunghee Cho Paik; Ivan Wick; Ashlee Bennett; Omar Jabado; David L Hirschberg; W Ian Lipkin
Journal:  PLoS One       Date:  2011-09-16       Impact factor: 3.240

Review 4.  Abnormalities in the zinc-metalloprotease-BDNF axis may contribute to megalencephaly and cortical hyperconnectivity in young autism spectrum disorder patients.

Authors:  Jae-Young Koh; Joon Seo Lim; Hyae-Ran Byun; Min-Heui Yoo
Journal:  Mol Brain       Date:  2014-09-03       Impact factor: 4.041

Review 5.  Inflammatory cytokines: potential biomarkers of immunologic dysfunction in autism spectrum disorders.

Authors:  Ningan Xu; Xiaohong Li; Yan Zhong
Journal:  Mediators Inflamm       Date:  2015-02-01       Impact factor: 4.711

6.  Serum and cerebrospinal fluid immune mediators in children with autistic disorder: a longitudinal study.

Authors:  Carlos A Pardo; Cristan A Farmer; Audrey Thurm; Fatma M Shebl; Jorjetta Ilieva; Simran Kalra; Susan Swedo
Journal:  Mol Autism       Date:  2017-01-05       Impact factor: 7.509

7.  Decreased Epidermal Growth Factor (EGF) Associated with HMGB1 and Increased Hyperactivity in Children with Autism.

Authors:  Anthony J Russo
Journal:  Biomark Insights       Date:  2013-04-04

8.  Increased Epidermal Growth Factor Receptor (EGFR) Associated with Hepatocyte Growth Factor (HGF) and Symptom Severity in Children with Autism Spectrum Disorders (ASDs).

Authors:  Anthony J Russo
Journal:  J Cent Nerv Syst Dis       Date:  2014-09-09

9.  Decreased Phosphorylated Protein Kinase B (Akt) in Individuals with Autism Associated with High Epidermal Growth Factor Receptor (EGFR) and Low Gamma-Aminobutyric Acid (GABA).

Authors:  Anthony J Russo
Journal:  Biomark Insights       Date:  2015-10-14

10.  Serum Epidermal Growth Factor is Low in Schizophrenia and Not Affected by Antipsychotics Alone or Combined With Electroconvulsive Therapy.

Authors:  Xiaobin Zhang; Wenhuan Xiao; KuanYu Chen; Yaqin Zhao; Fei Ye; Xiaowei Tang; Xiangdong Du
Journal:  Front Psychiatry       Date:  2020-03-03       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.